Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DIFLUOROMETHYLENE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2014/017643
Kind Code:
A1
Abstract:
The present invention relates to: a compound which has URAT1 inhibitory activity; and a URAT1 inhibitor, a blood uric acid level reducing agent and a pharmaceutical composition, each of which contains the compound. The present invention more specifically relates to a compound represented by formula (I). (In the formula, R1 represents -Q1-A1 or the like; R2 represents a hydrogen atom, a halogen atom, a lower alkyl group or the like; each of W1, W2, W3 and W4 independently represents a nitrogen atom, an optionally substituted methine group or the like; each of X and Y represents a single bond, an oxygen atom or the like; and Z represents a hydroxyl group, COOR3 or the like.)

Inventors:
NAGAI KEITA (JP)
BABA MOTOAKI (JP)
FUJIOKA SHINICHI (JP)
NAGASAWA KOH (JP)
TAKAHASHI HIROBUMI (JP)
KONDOH ERI (JP)
SOGO SACHIE (JP)
TANAKA KENICHI (JP)
ITOH YOSHIKI (JP)
Application Number:
PCT/JP2013/070359
Publication Date:
January 30, 2014
Filing Date:
July 26, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SATO PHARMA (JP)
International Classes:
C07D209/08; A61K31/404; A61K31/416; A61K31/437; A61K31/4439; A61K31/4709; A61K31/4725; A61P9/10; A61P13/04; A61P13/12; A61P19/02; A61P19/06; C07D231/56; C07D401/06; C07D401/14; C07D403/06; C07D409/06; C07D471/04
Domestic Patent References:
WO2006023704A22006-03-02
WO2006019831A12006-02-23
WO2005092890A22005-10-06
WO2010117932A12010-10-14
WO2011053292A12011-05-05
WO2008126898A12008-10-23
WO2012102405A12012-08-02
WO2006057460A12006-06-01
WO2007086504A12007-08-02
WO2009151695A12009-12-17
WO1998015530A11998-04-16
WO1999000372A11999-01-07
WO2007100066A12007-09-07
Foreign References:
JP2009528363A2009-08-06
Other References:
IAROSHENKO,V.O.: "Compound 14r", SYNTHESIS, 2009, pages 3967 - 3974, XP055187733
WOOLRIDGE,E.M. ET AL ET AL., TETRAHEDRON LETTERS, vol. 30, no. 45, 1989, pages 6117 - 6120, XP055187735
LOEB JN., ARTHRITIS RHUEUM., vol. 15, 1972, pages 189 - 192
JAPANESE SOCIETY OF GOUT AND NUCLEIC ACID METABOLISM: "Guideline of Hyperuricemia or Gout Treatment, 2nd ed.", 2010, pages: 30 - 31
CHOI HK. ET AL., ANN. INTERN. MED., vol. 43, 2005, pages 499 - 516
TANIGUCHI Y. ET AL., J. HYPERTENSION, vol. 19, 2001, pages 1209 - 1215
SUNDERSTROM J. ET AL., HYPERTENSION, vol. 45, 2005, pages 28 - 33
CHOI HK. ET AL., THE AM. J. MED., vol. 120, 2007, pages 442 - 447
ISHIZAKA N. ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., vol. 25, 2005, pages 1038 - 1044
MASAKO TOMITA; SHOICHI MIZUNO, GOUT AND NUCLEIC ACID METABOLISM, vol. 30, 2006, pages 1 - 5
TORU NAKAMURA: "Treatments of Hyperuricemia and Gout", 2003, MEDICAL REVIEW CO., LTD., pages: 21 - 39
SICA DA.; SCHOOLWERTH AC.: "The Kidney", 1996, SAUBDER, pages: 680 - 700
ENOMOTO A. ET AL., NATURE, vol. 417, 2002, pages 447 - 452
ICHIDA K. ET AL., J. AM. SOC. NEPHROL., vol. 15, 2004, pages 164 - 173
IWAO OHNO, JAPAN CLINICS, vol. 66, 2008, pages 743 - 747
T. W. GREENE: "Protective Groups in Organic Synthesis, 3rd ed.", 1999, JOHN WILEY & SONS
JOURNAL OF ORGANIC CHEMISTRY, vol. 74, 2009, pages 4547
TETRAHEDRON LETTERS, vol. 36, no. 11, 1995, pages 1759 - 1762
See also references of EP 2878594A4
Attorney, Agent or Firm:
TSUJII Koichi et al. (JP)
辻居 Koichi (JP)
Download PDF: